Abbott and Google Health unveiled a multi-year partnership to fuse Abbott's Lingo continuous glucose monitor data with Google Health's AI and app ecosystem, delivering personalized metabolic health insights.

Google Health Coach will use these integrated insights to offer tailored recommendations across nutrition, activity, sleep, and recovery to help users adopt healthier daily habits.

The real-world study accompanying the collaboration will guide future AI-guided guidance and deepen understanding of metabolic health in people without diabetes.

Market activity today showed a broadly neutral session for U.S. equities, with modest upswing for the Dow, a flat S&P 500, and a small decline for the Nasdaq, suggesting stock moves were driven by company-specific news.

The integration is not intended for medical use and availability may vary by device, with no fixed timeline beyond a later-in-2026 window.

Investors reacted positively to the combination of a high-profile tech partner, a large-scale study, and clear consumer adoption potential, nudging the stock higher in a directionless session.

The study aims to detect early signs of prediabetes to enable lifestyle interventions that reduce Type 2 diabetes risk.

The release underscores rising metabolic health issues like prediabetes and frames the partnership as a path to earlier, informed actions to slow related disease progression.

Public data cited shows over 115 million American adults have prediabetes, with about 80% unaware of their condition, highlighting potential impact on awareness and early intervention.

The collaboration references U.S. prediabetes prevalence data and aims to improve awareness and timely intervention for metabolic health challenges.

Lingo is available in the US and UK through retailers such as Amazon, Walmart, Walgreens, Best Buy, Publix, and hellolingo.com.